Hvilken er prisen på Ergomed plc (2EM)

Prisen på Ergomed plc (2EM) er $13.05

Hva er markedsverdien på Ergomed plc (2EM)

Markedsverdien på Ergomed plc (2EM) er $695.07M

Ergomed plc (2EM) Prishistorikk

Ergomed plc, alongside its affiliated entities, offers a comprehensive range of clinical trial services, encompassing planning, oversight, and execution, in addition to providing essential drug safety and medical information support. The company maintains an expansive global footprint, conducting operations throughout the United Kingdom, continental Europe, the Middle East, Africa, North America, Asia, and Australia. Its business is organized into two core divisions: Clinical Research Services and Pharmacovigilance. Ergomed assists pharmaceutical, biotechnology, and generic drug manufacturers by managing clinical development programs, facilitating post-market approval strategies, and delivering robust pharmacovigilance solutions. Their expertise is concentrated in several therapeutic domains, including oncology, haematology, allergy, respiratory, and neurology/CNS, with a notable specialization in the development of orphan drugs. Furthermore, they extend support services to clinical trial sites. Established in 1997, the organization originally traded as Ergomed Clinical Research Limited before rebranding as Ergomed plc in June 2014. Its corporate headquarters are situated in Guildford, United Kingdom.

År	Ytelse
2023	-19.23%
2022	-14.51%
2021	42.48%
2020	165.99%
2019	168.03%
2018	-27.38%
2017	35.65%
2016	-30.33%
2015	0.00%

År

Ytelse

2023

-19.23%

2022

-14.51%

2021

42.48%

2020

165.99%

2019

168.03%

2018

-27.38%

2017

35.65%

2016

-30.33%

2015

0.00%

Selskap	Aksjepris	Endring 1år%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.53	-12.70%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

Selskap

Aksjepris

Endring 1år%

Land